South Africa receives mlns more FDM vaccines to boost national vaccination campaign-Xinhua

The Strategic Shift in South Africa’s Battle Against Foot-and-Mouth Disease

South Africa is currently navigating a critical turning point in its livestock health strategy. With foot-and-mouth disease (FMD) outbreaks reported across all nine provinces, the government has pivoted toward a massive, international procurement strategy to protect the national herd and stabilize the agricultural economy.

The shift is evident in the recent acquisition of millions of vaccine doses from global suppliers. By partnering with Dollvet Biotechnology in Turkey through local agents Dunevax, and placing additional orders with Argentina-based Biogenesis Bago via Onderstepoort Biological Products (OBP), the Department of Agriculture is diversifying its supply chain to ensure steady access to matched vaccines.

The Path to International Red Meat Markets

The primary objective of this aggressive vaccination campaign extends beyond immediate containment. The ultimate goal is to achieve recognition from the World Organization of Animal Health (WOAH) as “FMD-free status with vaccination.”

For decades, South Africa’s access to lucrative international red meat markets has been closed due to the persistence of FMD. By securing matched vaccines from the international market and implementing a rigorous vaccination schedule, the country aims to reopen these trade corridors, providing a massive economic boost to livestock farmers.

Overcoming Logistics and Systemic Bottlenecks

Moving millions of doses across a vast geography requires more than just procurement; it requires precision logistics. The urgency of the FMD response has highlighted the importance of cold chain precision shipments to maintain vaccine efficacy during transport.

However, the road to recovery has not been without hurdles. Industry reports indicate that FMD strain testing had been stalled since 2011, and vaccination delays have previously exposed inefficiencies within the national response system. Addressing these systemic gaps is now a priority to ensure that the current influx of vaccines—including the 1.5 million doses partially delivered to the Western Cape—is utilized effectively.

Future Trends in Livestock Disease Management

Looking ahead, the South African approach suggests a trend toward greater reliance on international biotechnology partnerships and more stringent regulatory oversight. The requirement for import approval from the South African Health Products Regulatory Authority (SAHPRA) for shipments from Biogenesis Bago underscores a commitment to safety and quality control.

As the national herd continues to be vaccinated—with over two million animals already treated in recent months—the focus will likely shift toward sustainable surveillance and the modernization of strain testing to prevent the kind of stalls seen in previous decades.

Frequently Asked Questions